Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| 2-Cyano-N-(3,5-dichloro-4-methoxyphenyl)-acetamide | 1821033-10-6 | C10H8Cl2N2O2 | 259.09 | ||
| CYM 5541 | N,N-Dicyclohexyl-5-cyclopropyl-3-isoxazolecarboxamide, ML-249, CID-17253208 | 945128-26-7 | C19H28N2O2 | 316.44 | N,N-Dicyclohexyl-5-cyclopropyl-3-isoxazolecarboxamide, ML-249, CID-17253208
|
| (S)-Lisinopril-d5 Sodium | (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline-d5 Sodium | 1356847-28-3 | C21H26D5N3NaO5 | 433.51 | (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline-d5 Sodium |
| (S)-Lisinopril-d5 | (S)-1-[N2-(1-Carboxy-3-phenyl-d5-propyl)-L-lysyl]-L-proline; Acerbon-d5; Alapril-d5; Amicor-d5; Carace-d5; Cipral-d5; Cipril-d5; Coric-d5; Diroton-d5; Inopril-d5; Irumed-d5; Laaven-d5; Linopril-d5; Linvas-d5; Lipril-d5; Lisipril-d5; Lisitec-d5; Lisopril-d5; Lisoril-d5; Lispril-d5; Listril-d5; Lizinopril-d5; Lizonoton-d5; Longes-d5; Loril-d5; MK 521-d5; MK 522-d5; N-(1(S)-Carboxy-3-phenyl-d5-propyl)-L-lysyl-L-proline; N2-[(S)-1-Carboxy-3-phenyl-d5-propyl]-L-lysyl-L-proline; Nanopril-d5; Noperten-d5; Novatec-d5; Optimon-d5; Presiten-d5; Prinil-d5; Prinivil-d5; Prinvil-d5; Skopryl-d5; Tensopril-d5; Tensyn-d5; Vitopril-d5; Vivatec-d5; Zestril-d5 | 1356905-39-9 | C21H26D5N3O5 | 410.52 | (S)-1-[N2-(1-Carboxy-3-phenyl-d5-propyl)-L-lysyl]-L-proline; Acerbon-d5; Alapril-d5; Amicor-d5; Carace-d5; Cipral-d5; Cipril-d5; Coric-d5; Diroton-d5... |
| CYM 50308 | (2Z,5Z)-5-[[1-(2,4-Difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-2-[(2-methoxyethyl)imino]-3-methyl-4-thiazolidinone | 1345858-76-5 | C20H21F2N3O2S | 405.46 | (2Z,5Z)-5-[[1-(2,4-Difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-2-[(2-methoxyethyl)imino]-3-methyl-4-thiazolidinone
|
| 1092813-99-4 | (2S)-2-[(3S,8aRS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic Acid | 1092813-99-4 | C21H29N3O4 | 387.47 | (2S)-2-[(3S,8aRS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic Acid |
| Cystamine Dihydrochloride | 2,2’-Dithiobisethanamine Hydrochloride (1:2); 2,2’-Dithiobisethylamine Dihydrochloride; Bis(2-aminoethyl) Disulfide Dihydrochloride; Cystamine dichlorohydrate; Cystamine Hydrochloride; WR 352 | 56-17-7 | C4H14Cl2N2S2 | 225.2 | 2,2’-Dithiobisethanamine Hydrochloride (1:2); 2,2’-Dithiobisethylamine Dihydrochloride; Bis(2-aminoethyl) Disulfide Dihydrochloride; Cystamine di... |
| Lisinopril Cyclohexyl Analogue | N2-[(1S)-1-Carboxy-3-cyclohexylpropyl]-L-lysyl-L-proline (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrole-2-carboxylic Acid Lisinopril EP Impurity F | 1132650-67-9 | C21H37N3O5 | 411.54 | N2-[(1S)-1-Carboxy-3-cyclohexylpropyl]-L-lysyl-L-proline (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrole-2-carboxyl... |
| (R)-(-)-Etodolac | (1R)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (-)-(R)-Etodolac; (-)-Etodolac; (-)-Etodolic Acid; R-Etodolac; RAK 593; SDX 101; | 87226-41-3 | C17H21NO3 | 287.35 | (1R)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (-)-(R)-Etodolac; (-)-Etodolac; (-)-Etodolic Acid; R-Etodolac; RAK 593; SDX 101;... |
| (R)-(-)-Etodolac-d3 | (1R)-1,8-(Diethyl-d3)-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (-)-(R)-Etodolac-d3; (-)-Etodolac-d3; (-)-Etodolic Acid-d3; R-Etodolac-d3; RAK 593-d3; SDX 101-d3; | 1246815-33-7 | C17H18D3NO3 | 290.37 | (1R)-1,8-(Diethyl-d3)-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (-)-(R)-Etodolac-d3; (-)-Etodolac-d3; (-)-Etodolic Acid-d3; R-Etodolac-d3; ... |
Page 1495 of 10017